Results 31 to 40 of about 309,429 (287)
Lp-PLA2 mass and activity levels stratified by race in MESA.
, 2018 (A). Lp-PLA2 mass was measured using the PLACTM test (17). In Caucasians, Lp-PLA2 mass was 188.1 [164.8–213.5] ng/ml (median [IQR], N = 1968); African-Americans, 162.2 [136.5–188.1], N = 1166; Hispanic, 175.8 [153.9–198.5], N = 1138; and Chinese ...
Harvey White (5823983) +19 more
core +1 more source
Landslide Susceptibility Prediction from Satellite Data through an Intelligent System based on Deep Learning [PDF]
, 2023 Landslides are critical natural hazards whose frequency and severity are increasing due to climate change and human activities. The consequences of landslides are severe and can lead to the destruction of homes, infrastructures and the contamination of ...
Giuseppi, A +3 more
core +1 more source
Daring to dream: Targeting lipoprotein(a) as a causal and risk-enhancing factor
Pharmacological Research, 2023 Lipoprotein(a) [Lp(a)], a distinct lipoprotein class, has become a major focus for cardiovascular research. This review is written in light of the recent guideline and consensus statements on Lp(a) and focuses on 1) the causal association between Lp(a ...
Marlys L. Koschinsky +2 more
doaj +1 more source
Pediatric Blood &Cancer, EarlyView.ABSTRACT Background Pediatric sarcomas are a heterogeneous group of tumors that contribute disproportionately to cancer mortality in children. Although congenital anomalies are among the strongest known risk factors for childhood cancer, the risk of specific sarcoma subtypes among affected individuals has not yet been thoroughly evaluated. Procedure We
Russ Wolters +17 more
wiley +1 more source
Lipoproteins in Cardiovascular Calcification: Potential Targets and Challenges
Frontiers in Cardiovascular Medicine, 2018 Previously considered a degenerative process, cardiovascular calcification is now established as an active process that is regulated in several ways by lipids, phospholipids, and lipoproteins.
Yin Tintut +6 more
doaj +1 more source
Serum lipoprotein (a) and lipid profile in polycystic ovarian syndrome [PDF]
Journal of Clinical and Scientific Research, 2015 Background: Polycystic ovarian syndrome (PCOS) is associated with dyslipidaemia and may render the affected women “at risk” of developing cardiovascular disease.
Swetha R, Ravi BV, Nalini KS
doaj +1 more source
Reciprocal control of viral infection and phosphoinositide dynamics
FEBS Letters, EarlyView.Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley +1 more source
Frontiers in Cardiovascular MedicineBackgroundMultiple guidelines recommend detection of and early risk factor management for elevated lipoprotein(a) [Lp(a)]. Effective implementation requires assessment of knowledge and practices regarding elevated Lp(a) among medical specialists.AimTo ...
Wann Jia Loh +7 more
doaj +1 more source
Lipoprotein(a) – Link between Atherogenesis and Thrombosis
Prague Medical Report, 2019 Lipoprotein(a) – Lp(a) – is an independent risk factor for cardiovascular disease (CVD). Indeed, individuals with plasma concentrations of Lp(a) > 200 mg/l carry an increased risk of developing CVD. Circulating levels of Lp(a) are remarkably resistant to
Danica Labudovic +5 more
doaj +1 more source
Cardiovascular Diabetology, 2020 Background Merging studies have reported the association of lipoprotein(a) [Lp(a)] with poor outcomes of coronary artery disease (CAD) in patients with type 2 diabetes mellitus (T2DM).
Yan Zhang +11 more
doaj +1 more source